Comparison of the therapeutic performance of macrolide antibiotics on macrolide-resistant or macrolide-susceptible Mycoplasma pneumoniae pneumonia children - Takeaways - MDSpire

Comparison of the therapeutic performance of macrolide antibiotics on macrolide-resistant or macrolide-susceptible Mycoplasma pneumoniae pneumonia children

  • By

  • Yi-Qing Qiu

  • Xiao-Qian Chen

  • May 18, 2026

  • 0 min

Share

  • 1

    The study evaluated macrolide antibiotic efficacy in treating Mycoplasma pneumoniae pneumonia in pediatric patients with varying resistance profiles.

  • 2

    Out of 217 pediatric patients, 188 were classified as macrolide-resistant Mycoplasma pneumoniae, indicating a high resistance rate of 86.6%.

  • 3

    MRMP patients had a higher MP DNA load and longer duration of macrolide therapy compared to macrolide-susceptible patients.

  • 4

    The incidence of severe Mycoplasma pneumoniae pneumonia was lower in the MRMP group (5.8%) compared to the MSMP group (17.2%).

  • 5

    Macrolide treatment showed comparable clinical effectiveness in both MRMP and MSMP patients, warranting further evaluation of MP DNA load and treatment duration.

Original Source(s)

Comparison of the therapeutic performance of macrolide antibiotics on macrolide-resistant or macrolide-susceptible Mycoplasma pneumoniae pneumonia children

  • by Yi-Qing Qiu, Xiao-Qian Chen

  • May 18, 2026

Related Content

Flu Hospitalization Tied to Diabetes Risk

A large English cohort study found influenza hospitalization more than doubled the short-term risk of new-onset diabetes, with prediabetes and critical care admission among the strongest predictors.

Synthetic short peptide mimicking IsdB and IsdH conserved motifs selectively bind and enable detection of Staphylococcus aureus infection

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization